OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
57
Results
Show all
Save search
Copy query
Show results for
Unknown
(57)
Release Date
2024
(7)
2018
(7)
2025
(5)
2022
(5)
2019
(5)
2016
(4)
2017
(3)
2015
(3)
2014
(3)
2012
(3)
2026
(2)
2023
(2)
2021
(2)
2020
(2)
2013
(2)
2011
(1)
2010
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
Not available
S-EPMC3398767
|
biostudies-literature
Cite
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903
|
biostudies-literature
Cite
Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial.
Not available
S-EPMC9270696
|
biostudies-literature
Cite
Interventions to improve continence for children and young people with neurodisability: a national survey of practitioner and family perspectives and experiences.
Not available
S-EPMC10806478
|
biostudies-literature
Cite
Feasibility work to inform the design of a randomized clinical trial of wound dressings in elective and unplanned abdominal surgery.
Not available
S-EPMC5091629
|
biostudies-literature
Cite
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
Not available
S-EPMC10906954
|
biostudies-literature
Cite
The National Lung Matrix Trial of personalized therapy in lung cancer.
Not available
S-EPMC7116732
|
biostudies-literature
Cite
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Not available
S-EPMC8927425
|
biostudies-literature
Cite
Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency.
Not available
S-EPMC11032109
|
biostudies-literature
Cite
The impact of inversions across 33,924 families with rare disease from a national genome sequencing project.
Not available
S-EPMC11179413
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets